Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Olaguoke Akinwande

Vascular & Interventional Radiology Saint Louis, MO Medical Doctor

NPI 1235362252 CMS profile 1384095

12855 N 40 Dr Ste 205, Saint Louis, MO 63141

Open in the dashboard

General payments

$21,464

140 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Olaguoke Akinwande of Saint Louis, MO is reported in the CMS Open Payments database as having received $21,464 across 140 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $906 19
2024 General $3,952 20
2023 General $5,134 27
2022 General $8,599 15
2021 General $887 26
2020 General $234 13
2019 General $1,752 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Olaguoke Akinwande
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Olaguoke Akinwande were reported at $906. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Olaguoke Akinwande Vascular & Interventional Radiology median Middle half National median
2019 $1,752 $422 $125–$1,555 $163
2020 $234 $200 $68–$652 $114
2021 $887 $280 $99–$866 $132
2022 $8,599 $433 $137–$1,497 $149
2023 $5,134 $506 $152–$2,019 $160
2024 $3,952 $556 $175–$1,930 $164
2025 $906 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Philips Electronics North America Corporation $10,275 52 payments
  2. Terumo Medical Corporation $4,944 11 payments
  3. Siemens Medical Solutions USA, Inc. $2,524 3 payments
  4. Nevro Corp. $871 6 payments
  5. Abbott Laboratories $686 25 payments
  6. Boston Scientific Corporation $598 11 payments
  7. Cordis US Corp. $251 3 payments
  8. Bard Peripheral Vascular, Inc. $221 3 payments
  9. Medtronic, Inc. $153 2 payments
  10. Penumbra, Inc. $147 1 payment
  11. Other $794 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $11,635 4 payments
  2. Food and Beverage $6,013 131 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,400 1 payment
  4. Travel and Lodging $1,416 4 payments
Products named General payments · program years 2019–2025
  1. (9520) IGT Devices Undivided $3,707 4 payments
  2. (9520) IGT Devices Und $3,691 2 payments
  3. Senza $871 6 payments
  4. IGT D Peripheral $861 2 payments
  5. (6554) Peripheral Vascular Undivided $681 8 payments
  6. (9281) Turbo Elite $490 4 payments
  7. Azur CX Detachable $239 2 payments
  8. VENOVO $197 2 payments
  9. ABSOLUTE PRO $167 1 payment
  10. (5027) Intact Vascular Und $160 3 payments
  11. Other $3,736 108 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

293

Median for Interventional Radiology: 38

Drug cost

$82,251

Median for Interventional Radiology: $333

Branded share of claims

100%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 44 $45,243
Eliquis Apixaban Brand 43 $34,950
Clopidogrel Clopidogrel Bisulfate Brand 206 $2,058

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$965,940

Medicare's payments for the services billed

Medicare patients

185

Average age 73

Services billed

1,123

84 women, 101 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Diabetes 56%
Chronic kidney disease 48%
Ischemic heart disease 41%
Depression 35%
Heart failure 33%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • E.R. Squibb & Sons, L.L.C. $19
$19 43 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record